Dr Reddy's Laboratories (FRA:RDDA) Other Long-Term Liabilities : €37 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Dr Reddy's Laboratories Other Long-Term Liabilities?

Dr Reddy's Laboratories's other long-term liabilities for the quarter that ended in Mar. 2024 was €37 Mil.

Dr Reddy's Laboratories's quarterly other long-term liabilities increased from Sep. 2023 (€24 Mil) to Dec. 2023 (€31 Mil) and increased from Dec. 2023 (€31 Mil) to Mar. 2024 (€37 Mil).

Dr Reddy's Laboratories's annual other long-term liabilities increased from Mar. 2022 (€11 Mil) to Mar. 2023 (€15 Mil) and increased from Mar. 2023 (€15 Mil) to Mar. 2024 (€37 Mil).

Dr Reddy's Laboratories Other Long-Term Liabilities Historical Data

The historical data trend for Dr Reddy's Laboratories's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Reddy's Laboratories Other Long-Term Liabilities Chart

Dr Reddy's Laboratories Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Other Long-Term Liabilities

Get a 7-Day Free Trial

Dr Reddy's Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Dr Reddy's Laboratories Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Dr Reddy's Laboratories Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Dr Reddy's Laboratories's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr Reddy's Laboratories (FRA:RDDA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dr Reddy's Laboratories Ltd (FRA:RDDA) » Definitions » Other Long-Term Liabilities

Traded in Other Exchanges

RDY:USA DRREDDY:India 500124:India RDDA:Germany R1DY34:Brazil

Address

8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034

Website

https://www.drreddys.com

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (22% of its generics sales), Russia (12%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Dr Reddy's Laboratories (FRA:RDDA) Headlines

No Headlines